Periodic courses of human 1-34 parathyroid peptide alternating with calcitriol paradoxically reduce bone remodelling in spinal osteoporosis.
In an attempt to achieve an anabolic response in both axial and peripheral bone, we treated twelve patients with osteoporosis using human 1-34 parathyroid peptide given discontinuously. The peptide was given as seven daily subcutaneous injections followed by 21 days' treatment with 0.25 mg calc...
المؤلفون الرئيسيون: | Reeve, J, Arlot, M, Price, T, Edouard, C, Hesp, R, Hulme, P, Ashby, J, Zanelli, J, Green, JR, Tellez, M |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
1987
|
مواد مشابهة
-
A short-cycle ADFR regimen using parathyroid peptide hPTH 1–34 in idiopathic osteoporosis
حسب: Reeve, J, وآخرون
منشور في: (1986) -
Human parathyroid peptide treatment of vertebral osteoporosis.
حسب: Reeve, J, وآخرون
منشور في: (1993) -
hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses.
حسب: Reeve, J, وآخرون
منشور في: (1991) -
Gastrointestinal calcium absorption and dietary calcium load: relationships with bone remodelling in vertebral osteoporosis.
حسب: Tellez, M, وآخرون
منشور في: (1995) -
The relationship between changes in femoral bone density and calcium balance in patients with involutional osteoporosis treated with human parathyroid hormone fragment (hPTH 1–34)
حسب: Hesp, R, وآخرون
منشور في: (1981)